Buck Wealth Strategies’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-325
Closed -$9.07K – 84
2023
Q3
$9.07K Buy
+325
New +$10.6K ﹤0.01% 205

Other funds holding ARKG

Buck Wealth Strategies's ARKG Position: Q4 2023 in Review

Buck Wealth Strategies sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 325 shares — an estimated $9.07K sold.

Buck Wealth Strategies first reported a position in ARKG in Q3 2023 and held it in 1 quarter. The position peaked at $9.07K in Q3 2023. 300 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Buck Wealth Strategies reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Buck Wealth Strategies sold 325 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $9.07K.
  • Buck Wealth Strategies first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 1 quarter.
  • Buck Wealth Strategies's ARK Genomic Revolution ETF position peaked at $9.07K in Q3 2023.
  • 300 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Buck Wealth Strategies's 13F filing for Q4 2023, filed 23 Jan 2024.